Anavex Life Sciences Corp (AVXL)

[drv17]

--------------------------------------------------------------------
Another variable much harder to determine is how individual genetic
differences impact the drug.
--------------------------------------------------------------------

I have been a participant Mayo Clinic's Biobank research since 2012 and have recently been contacted to participate
in a new study entitled "Right Drug, Right Dose, Right Time-Using Genomic Data to Individualized Treatment (Right Protocol)"
This is to be an open ended study with an additional 12,000 participant to the original 1013 participants in the original .

The clinic will put some genetic information in our medical records that will fall into two categories.
"1. Genetic variants that may affect how your body responds to certain prescription drugs."
"2. Other genetic factors that may be important to your health."

It appears that Anavex Life Science's team is ahead of the curve with their approach of looking at sub groups utilizing Ariana and Kem.